View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
April 27, 2017

Takeda and Harrington Discovery Institute to advance rare disease therapeutics development

Takeda Pharmaceutical Company and Harrington Discovery Institute at University Hospitals in Cleveland, Ohio, have entered a multi-year collaboration to advance breakthrough therapeutic discoveries in rare diseases.

Takeda Pharmaceutical Company and Harrington Discovery Institute at University Hospitals in Cleveland, Ohio, have entered a multi-year collaboration to advance breakthrough therapeutic discoveries in rare diseases.

The collaboration will leverage on Harrington Discovery Institute’s established operating model to create a new programme to advance the development of medicines for rare diseases.

The partnership is also expected to upgrade Takeda ’s strategic R&D focus in its therapeutic areas of oncology, gastroenterology and central nervous system disorders.

The Harrington programme will assist MD and PhD researchers from the US to carry out disruptive and transformative research, which will help with developing new treatments.

Takeda centre for external innovation head Daniel Curran said: “This collaboration is another example of how Takeda is focused on fostering partnerships between academia and industry and its increasing commitment to the development of medicines in rare diseases, particularly in our therapeutic areas of focus in oncology, gastroenterology and central nervous system disorders.

"Our collaboration demonstrates a new way of business that is driven by a shared vision and mission."

“We believe Harrington Discovery Institute has a unique structure that is immensely helpful to academic researchers who are developing novel therapeutics that can result in a significant impact for patients.

“Our collaboration demonstrates a new way of business that is driven by a shared vision and mission.”

Researchers of this new programme will have access to funding from the Harrington Discovery Institute and learn drug development capability and project management from Innovation Support Center experts.

Furthermore, the researchers will also have access to Takeda ’s internal research and development experts.

The Harrington Discovery Institute at University Hospitals , part of The Harrington Project for Discovery and Development, focuses on advancing medicinal development by assisting the scientists with evolving their discoveries into medicines.

The institute was created in 2012 with a $50m funding from the Harrington family.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology